Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...

Leah Witt, MD: Hello. I'm Dr Leah Witt. Welcome back to season one of the Medscape inDiscussion chronic obstructive pulmonary disease (COPD) podcast series. Today, we're talking pulmonary rehab, the ...

Some patients with chronic obstructive pulmonary disease, or COPD, are breathing easier thanks to new technology in the form of a small valve inserted in the lung. Paula Dote had the Zephyr valves ...

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management. Chronic obstructive ...

– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for ...

Reviewed by Ware Kuschner, MD, Professor of Medicine, Division of Pulmonary, Allergy, & Critical Care Medicine, Stanford University School of Medicine Among adults with chronic obstructive pulmonary ...

An overview of COPD management programs available and offered by payers to members to help support patient adherence to chronic obstructive pulmonary disease therapies. Neil Minkoff, MD: What are the ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

NEW YORK, Sept. 20 (UPI) --Recent advances in chronic obstructive pulmonary disease offer patients more hope in easing discomfort from a condition that can cause severe airflow blockage and ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: ...

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -- dupilumab -- that showed rapid and sustained improvements in patients in a pivotal Phase 3 ...

In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...